English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

With the development of CT technology and the initiation of CT screening for lung cancer, many small nodules, especially ones exhibiting ground glass opacity (GGO) on CT images, are now frequently detected. How these small nodules should be managed remains a topic of interest. We previously reported the results of a long-term follow-up of 243 patients with pure or mixed GGOs of 3 cm or smaller in size1. Of these 243 patients, 39 patients showed tumor growth during the follow-up period. In contrast, 82 patients did not exhibit any tumor growth during the follow-up period. The identification of GGOs with a high likelihood of future growth or stable disease at the time of the first hospital visit would be both interesting and helpful. We therefore analyzed the data of the previous study and attempted to identify clinical factors that were associated with future tumor growth or stable disease.

journal of lung health and diseases

Commentary: Long-term Outcomes of Patients With Ground-Glass Opacities Detected Using CT Scanning Can we predict future tumor growth at the time of the first hospital visit?